Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» polymyositis
polymyositis
Amgen spinout Kezar hits PhII hurdle, all eyes on June readout for drug’s other study
Endpoints
Wed, 05/4/22 - 10:39 am
Amgen
Kezar Life Sciences
zetomipzomib
autoimmune disease
dermatomyositis
polymyositis